Immune - cell death index in hepatocellular carcinoma: a multi-omics and machine learning study for prognosis and immunotherapy prediction - Scorecard - MDSpire

Immune - cell death index in hepatocellular carcinoma: a multi-omics and machine learning study for prognosis and immunotherapy prediction

  • By

  • Yi Zhang

  • Haiyu Zhao

  • Yunpeng Zhai

  • Chongyang Wang

  • Zhenya Wang

  • Ruopeng Liang

  • June 11, 2026

  • 0 min

Share

Clinical Scorecard: Assessment of Immune-Related Cell Death Indicators in Hepatocellular Carcinoma: A Multi-Omics Approach Combined with Machine Learning for Prognostic and Immunotherapy Insights

At a Glance

CategoryDetail
Condition
Key MechanismsProgrammed cell death (PCD) and immune-related genes in HCC progression
Target Population
Care Setting

Key Highlights

  • highlight_5

Guideline-Based Recommendations

Diagnosis

    Management

      Monitoring & Follow-up

      • Monitor HICDI scores to assess prognosis and treatment response, including specific metrics such as changes in score over time.

      Risks

        Patient & Prescribing Data

        Consider additional treatment options for patients with high HICDI scores, such as targeted therapies or combination treatments.

        Clinical Best Practices

        • best_practice_1

        Related Resources & Content

        Original Source(s)

        Immune - cell death index in hepatocellular carcinoma: a multi-omics and machine learning study for prognosis and immunotherapy prediction

        • by Yi Zhang, Haiyu Zhao, Yunpeng Zhai, Chongyang Wang, Zhenya Wang, Ruopeng Liang

        • June 11, 2026

        Related Content

        Subsite-specific benefit of induction chemoimmunotherapy in HPV-negative oropharyngeal squamous cell carcinoma

        Case Report: Granular cell tumor of the axillary tail mimicking node-positive breast carcinoma — two cases with imaging–pathology correlation

        Fibromyalgia in cancer patients: a systematic review and clinical implications for integrated care